The Sen­ate Health, Ed­u­ca­tion, La­bor & Pen­sions Com­mit­tee voted 21-2 to ap­prove a bi­par­ti­san bill

Modern Healthcare - - LATE NEWS -

that reau­tho­rized the Food and Drug Ad­min­is­tra­tion’s abil­ity to col­lect user fees from those who make pre­scrip­tion brand drugs, med­i­cal de­vices, generic drugs and biosim­i­lars. The com­mit­tee added sev­eral amend­ments to the bill, in­clud­ing one that sets a time frame of no more than eight months for the FDA to pri­or­i­tize the re­view of new drugs in­tro­duced into un­com­pet­i­tive mar­kets. Another re­quires the FDA, the Na­tional In­sti­tutes of Health and other stake­hold­ers to as­sem­ble a pub­lic meet­ing to dis­cuss the po­ten­tial bar­ri­ers for pa­tients to par­tic­i­pate in clin­i­cal tri­als.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.